Aktiesnakken — Januar 2012
-
Dendreon attributed the boost to improved insurance reimbursement for the product, noting that the average reimbursement period for prescribing physicians had dropped to less than 30 days.
-
-
@aspek det er fordi den er forsinket kursen.
-
den stiger til 42 men sigter mod 38? Var det ikke omvendt igår?
-
den er fræk fordi den gør det modsatte af det den gør
-
At the end of the fourth quarter, completed in-servicing for more than 840 total sites, of which: -- More than 590 sites have infused PROVENGE, which represents the greatest growth in infusing sites quarter over quarter;
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind